Computational modeling of structure-function of g protein-coupled receptors with applications for drug design.

G protein-coupled receptors (GPCRs) mediate senses such as odor, taste, vision, and pain in mammals. In addition, important cell recognition and communication processes often involve GPCRs. Many diseases involve malfunction of GPCRs, making them important targets for drug development. Indeed, greater than 50 % of all marketed therapeutics act on those receptors. Unfortunately, the atomic-level structures are only available for rhodopsin, beta2AR, beta1AR, A2A adenosin and opsin. In silico computational methods, employing receptor-based modeling, offer a rational approach in the design of drugs targeting GPCRs. These approaches can be used to understand receptor selectivity and species specificity of drugs that interact with GPCRs. This review gives an overview of current computational approaches to GPCR model building; ligand-receptor interaction for drug design; and molecular mechanism of GPCR activation from simulation.

[1]  W. Goddard,et al.  Structure of polyamidoamide dendrimers up to limiting generations: a mesoscale description. , 2009, The Journal of chemical physics.

[2]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[3]  Oliver P. Ernst,et al.  Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.

[4]  Patrick Scheerer,et al.  Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.

[5]  Tomas Perez-Acle,et al.  Computational modeling study of functional microdomains in cannabinoid receptor type 1. , 2008, Bioorganic & medicinal chemistry.

[6]  Nagarajan Vaidehi,et al.  Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation. , 2008, Biophysical journal.

[7]  Youyong Li,et al.  PREDICTION OF THE STRUCTURE OF G-PROTEIN COUPLED RECEPTOR WITH APPLICATION FOR DRUG DESIGN , 2008 .

[8]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[9]  Abdelazize Laoui,et al.  Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist. , 2007, Journal of the American Chemical Society.

[10]  R. Zauhar,et al.  Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation. , 2006, Journal of molecular graphics & modelling.

[11]  Francesca Fanelli,et al.  Inactive and active states and supramolecular organization of GPCRs: insights from computational modeling , 2006, J. Comput. Aided Mol. Des..

[12]  Youyong Li,et al.  Continuous self-avoiding walk with application to the description of polymer chains. , 2006, The journal of physical chemistry. B.

[13]  T. Schwartz,et al.  Molecular mechanism of 7TM receptor activation--a global toggle switch model. , 2006, Annual review of pharmacology and toxicology.

[14]  Francesca Fanelli,et al.  Computational modeling approaches to structure-function analysis of G protein-coupled receptors. , 2005, Chemical reviews.

[15]  Gunnar von Heijne,et al.  Transmembrane helices before, during, and after insertion. , 2005, Current opinion in structural biology.

[16]  G. Schertler Structure of rhodopsin and the metarhodopsin I photointermediate. , 2005, Current opinion in structural biology.

[17]  Leonardo Pardo,et al.  A three-dimensional pharmacophore model for 5-hydroxytryptamine6 (5-HT6) receptor antagonists. , 2005, Journal of medicinal chemistry.

[18]  M. Lohse,et al.  Molecular basis of inverse agonism in a G protein–coupled receptor , 2005, Nature chemical biology.

[19]  Giuseppe Nano,et al.  2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors. , 2005, Journal of medicinal chemistry.

[20]  M. Mor,et al.  Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models. , 2005, Journal of medicinal chemistry.

[21]  Elizabeth Buck,et al.  Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Riccardo Petrelli,et al.  Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists. , 2005, Journal of medicinal chemistry.

[23]  K. Katoh,et al.  MAFFT version 5: improvement in accuracy of multiple sequence alignment , 2005, Nucleic acids research.

[24]  Francesca Deflorian,et al.  Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study. , 2005, Journal of medicinal chemistry.

[25]  Peter Gmeiner,et al.  Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes. , 2005, Journal of medicinal chemistry.

[26]  W. Millard,et al.  Structural characterization and pharmacology of a potent (Cys101-Cys119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist. , 2004, Journal of medicinal chemistry.

[27]  R. Kiss,et al.  Homology modelling and binding site mapping of the human histamine H1 receptor. , 2004, European journal of medicinal chemistry.

[28]  Richard A Friesner,et al.  An Automatic Method for Predicting Transmembrane Protein Structures Using Cryo-em and Evolutionary Data , 2004 .

[29]  K. Jacobson,et al.  Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. , 2004, Journal of medicinal chemistry.

[30]  W. Goddard,et al.  Selectivity and specificity of substrate binding in methionyl‐tRNA synthetase , 2004, Protein Science.

[31]  Nagarajan Vaidehi,et al.  Predicted 3-D structures for mouse I7 and rat I7 olfactory receptors and comparison of predicted odor recognition profiles with experiment. , 2004, Chemical senses.

[32]  D. Major,et al.  Molecular recognition in purinergic receptors. 1. A comprehensive computational study of the h-P2Y1-receptor. , 2004, Journal of medicinal chemistry.

[33]  Christopher A Reynolds,et al.  Toward the active conformations of rhodopsin and the β2‐adrenergic receptor , 2004, Proteins.

[34]  S. Moro,et al.  1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies. , 2004, Journal of medicinal chemistry.

[35]  Kurt Kristiansen,et al.  Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. , 2004, Pharmacology & therapeutics.

[36]  Antti Poso,et al.  Development of a 3D model for the human cannabinoid CB1 receptor. , 2004, Journal of medicinal chemistry.

[37]  Patrick Jimonet,et al.  Strategies for designing GPCR-focused libraries and screening sets. , 2004, Current opinion in drug discovery & development.

[38]  Nagarajan Vaidehi,et al.  Making sense of olfaction through predictions of the 3-D structure and function of olfactory receptors. , 2004, Chemical senses.

[39]  Andrzej Wilczynski,et al.  Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. , 2004, Journal of medicinal chemistry.

[40]  Peter L. Freddolino,et al.  The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Didier Rognan,et al.  High-Throughput Modeling of Human G-Protein Coupled Receptors: Amino Acid Sequence Alignment, Three-Dimensional Model Building, and Receptor Library Screening , 2004, J. Chem. Inf. Model..

[42]  Francesca Fanelli,et al.  Synthesis, Screening, and Molecular Modeling of New Potent and Selective Antagonists at the α1d Adrenergic Receptor , 2004 .

[43]  Peter L. Freddolino,et al.  Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Nagarajan Vaidehi,et al.  HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases. , 2004, Journal of medicinal chemistry.

[45]  Stephen C Peiper,et al.  Lipid Bilayer Simulations of CXCR4 with Inverse Agonists and Weak Partial Agonists* , 2003, Journal of Biological Chemistry.

[46]  L. Pardo,et al.  Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives. , 2003, Journal of medicinal chemistry.

[47]  Kenneth A Jacobson,et al.  Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists. , 2003, Journal of medicinal chemistry.

[48]  Didier Rognan,et al.  Identification of the Binding Sites of the SR49059 Nonpeptide Antagonist into the V1a Vasopressin Receptor Using Sulfydryl-reactive Ligands and Cysteine Mutants as Chemical Sensors* , 2003, Journal of Biological Chemistry.

[49]  William A. Goddard,et al.  Fidelity of Phenylalanyl-tRNA Synthetase in Binding the Natural Amino Acids , 2003 .

[50]  I. Forbes,et al.  CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach. , 2003, Journal of medicinal chemistry.

[51]  Adrian A Canutescu,et al.  Access the most recent version at doi: 10.1110/ps.03154503 References , 2003 .

[52]  Simona Collina,et al.  Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity. , 2003, Journal of medicinal chemistry.

[53]  Krzysztof Palczewski,et al.  Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. , 2003, Biochemistry.

[54]  Krzysztof Palczewski,et al.  Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Wely B. Floriano,et al.  Interaction of e. coli outer‐membrane protein A with sugars on the receptors of the brain microvascular endothelial cells , 2002, Proteins.

[56]  Gert Vriend,et al.  GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..

[57]  Nagarajan Vaidehi,et al.  Virtual screening for binding of phenylalanine analogues to phenylalanyl-tRNA synthetase. , 2002, Journal of the American Chemical Society.

[58]  Shigeyuki Yokoyama,et al.  Conformation of ligands bound to the muscarinic acetylcholine receptor. , 2002, Molecular pharmacology.

[59]  Molecular Structure and Function of 7TM G- Protein- Coupled Receptors , 2002 .

[60]  Kenneth A. Jacobson,et al.  Structural Determinants of A3 Adenosine Receptor Activation: Nucleoside Ligands at the Agonist/Antagonist Boundary , 2002 .

[61]  S. Moro,et al.  Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonist. , 2002, Journal of medicinal chemistry.

[62]  K. Katoh,et al.  MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. , 2002, Nucleic acids research.

[63]  S. Sagan,et al.  Involvement of the Second Extracellular Loop (E2) of the Neurokinin-1 Receptor in the Binding of Substance P , 2002, The Journal of Biological Chemistry.

[64]  T. Sakmar,et al.  Evidence that helix 8 of rhodopsin acts as a membrane-dependent conformational switch. , 2002, Biochemistry.

[65]  K. Jacobson,et al.  Identification by Site-directed Mutagenesis of Residues Involved in Ligand Recognition and Activation of the Human A3 Adenosine Receptor* , 2002, The Journal of Biological Chemistry.

[66]  W. Goddard,et al.  Structure-based design of mutant Methanococcus jannaschii tyrosyl-tRNA synthetase for incorporation of O-methyl-l-tyrosine , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  W. Goddard,et al.  Mechanism for antibody catalysis of the oxidation of water by singlet dioxygen , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Barbara Cacciari,et al.  Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists. , 2002, Journal of medicinal chemistry.

[69]  J. Wess,et al.  Conformational Changes That Occur during M3Muscarinic Acetylcholine Receptor Activation Probed by the Use of an in Situ Disulfide Cross-linking Strategy* , 2002, The Journal of Biological Chemistry.

[70]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[71]  J. Klein-Seetharaman,et al.  Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 316 in helix 8 and residues in the sequence 60-75, covering the cytoplasmic end of helices TM1 and TM2 and their connection loop CL1. , 2001, Biochemistry.

[72]  K. Jacobson,et al.  Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides. , 2001, Journal of medicinal chemistry.

[73]  E. Meng,et al.  Receptor activation: what does the rhodopsin structure tell us? , 2001, Trends in pharmacological sciences.

[74]  J. Ballesteros,et al.  Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. , 2001, Molecular pharmacology.

[75]  T. Schwartz,et al.  Partial agonism through a zinc-Ion switch constructed between transmembrane domains III and VII in the tachykinin NK(1) receptor. , 2000, Molecular pharmacology.

[76]  R. Lefkowitz The superfamily of heptahelical receptors , 2000, Nature Cell Biology.

[77]  U. Gether Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.

[78]  T. Schwartz,et al.  Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[79]  P Ghanouni,et al.  Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. , 1999, Molecular pharmacology.

[80]  Andrei L. Lomize,et al.  Structural organization of G-protein-coupled receptors , 1999, J. Comput. Aided Mol. Des..

[81]  C Altenbach,et al.  Structural features and light-dependent changes in the sequence 306-322 extending from helix VII to the palmitoylation sites in rhodopsin: a site-directed spin-labeling study. , 1999, Biochemistry.

[82]  J. Klein-Seetharaman,et al.  Structural features and light-dependent changes in the sequence 59-75 connecting helices I and II in rhodopsin: a site-directed spin-labeling study. , 1999, Biochemistry.

[83]  William A. Goddard,et al.  PROTEIN FOLD DETERMINATION FROM SPARSE DISTANCE RESTRAINTS : THE RESTRAINED GENERIC PROTEIN DIRECT MONTE CARLO METHOD , 1999 .

[84]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[85]  S. Satoh,et al.  The key amino acid residue of prostaglandin EP3 receptor for governing G protein association and activation steps. , 1999, Biochemical and biophysical research communications.

[86]  M. Caron,et al.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.

[87]  D. Farrens,et al.  Conformational Changes in Rhodopsin , 1999, The Journal of Biological Chemistry.

[88]  G. Schertler,et al.  Characterisation of an improved two-dimensional p22121 crystal from bovine rhodopsin. , 1998, Journal of molecular biology.

[89]  A. Lomize,et al.  Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints. , 1998, Biophysical journal.

[90]  S. Sealfon,et al.  Rhodopsin-family receptors associate with small G proteins to activate phospholipase D , 1998, Nature.

[91]  Juan Jesús Pérez,et al.  BUNDLE: A program for building the transmembrane domains of G-protein-coupled receptors , 1998, J. Comput. Aided Mol. Des..

[92]  Heidi E. Hamm,et al.  The Many Faces of G Protein Signaling* , 1998, The Journal of Biological Chemistry.

[93]  J. Baldwin,et al.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.

[94]  Todd J. A. Ewing,et al.  Critical evaluation of search algorithms for automated molecular docking and database screening , 1997, J. Comput. Chem..

[95]  A. Lomize,et al.  The transmembrane 7-alpha-bundle of rhodopsin: distance geometry calculations with hydrogen bonding constraints. , 1997, Biophysical journal.

[96]  M. Cocchi,et al.  Alpha 1-adrenoceptor subtype selectivity: molecular modelling and theoretical quantitative structure-affinity relationships. , 1997, Bioorganic & medicinal chemistry.

[97]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[98]  Stephen H. White,et al.  Experimentally determined hydrophobicity scale for proteins at membrane interfaces , 1996, Nature Structural Biology.

[99]  O. Lichtarge,et al.  Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F , 1996, Nature.

[100]  H. Khorana,et al.  Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. , 1996, Biochemistry.

[101]  G. Loew,et al.  A 3D model of the δ opioid receptor and ligand-receptor complexes , 1996 .

[102]  Martin J. Lohse,et al.  Mutations of Tyr326 in the β2-adrenoceptor disrupt multiple receptor functions , 1996 .

[103]  Abhinandan Jain,et al.  Constant temperature constrained molecular dynamics: The Newton-Euler inverse mass operator method , 1996 .

[104]  M. Menziani,et al.  Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors. , 1996, Journal of medicinal chemistry.

[105]  M C Peitsch,et al.  Automated modelling of the transmembrane region of G-protein coupled receptor by Swiss-model. , 1996, Receptors & channels.

[106]  P Herzyk,et al.  Automated method for modeling seven-helix transmembrane receptors from experimental data. , 1995, Biophysical journal.

[107]  B. Kobilka,et al.  Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. , 1995, The Journal of biological chemistry.

[108]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[109]  W. Greenlee,et al.  Identification of peptide binding residues in the extracellular domains of the AT1 receptor. , 1994, The Journal of biological chemistry.

[110]  Marina Cocchi,et al.  The heuristic-direct approach to theoretical quantitative structure activity relationship analysis of α1- adrenoceptor ligands , 1994 .

[111]  T. Schwartz,et al.  Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[112]  C. Strader,et al.  Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions. , 1994, Molecular pharmacology.

[113]  T L Blundell,et al.  The evolution and structure of aminergic G protein-coupled receptors. , 1994, Receptors & channels.

[114]  Marina Cocchi,et al.  The heuristic-direct approach to quantitative structure-activity relationship analysis , 1993 .

[115]  S. Nakanishi,et al.  Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist , 1993, Nature.

[116]  C. Strader,et al.  Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. , 1992, The Journal of biological chemistry.

[117]  C. Strader,et al.  The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides. , 1992 .

[118]  S. Chaki,et al.  Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis. , 1992, Biochemical and biophysical research communications.

[119]  L. F. Kolakowski,et al.  Expression cloning and characterization of the canine parietal cell gastrin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[120]  W. C. Probst,et al.  Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.

[121]  Frank McCormick,et al.  The GTPase superfamily: conserved structure and molecular mechanism , 1991, Nature.

[122]  S. L. Mayo,et al.  DREIDING: A generic force field for molecular simulations , 1990 .

[123]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[124]  C. Strader,et al.  Structural basis of β‐adrenergic receptor function , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[125]  Irving S. Sigal,et al.  Ligand binding to the β-adrenergic receptor involves its rhodopsin-like core , 1987, Nature.